Bellevue Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,960,131
| Closed | -$22.6M | – | 162 |
|
|
2022
Q4 | $22.6M | Sell |
2,960,131
-319,489
| -10% | -$2.44M | 0.3% | 78 |
|
|
2022
Q3 | $23.4M | Sell |
3,279,620
-259,435
| -7% | -$1.85M | 0.34% | 77 |
|
|
2022
Q2 | $28.6M | Buy |
3,539,055
+393,762
| +13% | +$3.19M | 0.4% | 67 |
|
|
2022
Q1 | $43.7M | Buy |
3,145,293
+1,176,862
| +60% | +$16.3M | 0.51% | 62 |
|
|
2021
Q4 | $55.2M | Buy |
1,968,431
+632,408
| +47% | +$17.7M | 0.57% | 59 |
|
|
2021
Q3 | $45.4M | Buy |
1,336,023
+373,671
| +39% | +$12.7M | 0.46% | 68 |
|
|
2021
Q2 | $39.3M | Buy |
+962,352
| New | +$39.3M | 0.38% | 80 |
|